The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Triple-negative breast cancer (TNBC) comprises about 10-20% of all diagnosed breast cancers. Increasing evidence shows that the omega-3 polyunsaturated fatty acids (ω-3PUFAs), docosahexaenoic acid and eicosapentaenoic acid, can influence the development, progression, and prognosis of TNBC In Vivo and In Vitro; however, clinical evidence supporting the effect of ω-3PUFAs on TNBC is lacking. Research has demonstrated that ω-3PUFAs can induce apoptosis in breast cancer cells by inhibiting the PI3K/AKT signal transduction pathway, and that ω-3PUFAs can improve the effectiveness of chemotherapy drugs. Using ω-3PUFA supplementation in addition to pharmacotherapy in the treatment of breast cancer may result in enhanced anti-tumor effects that will be particularly applicable to difficult to treat phenotypes such as TNBC. The aim of the current review was to summarize the evidence-base supporting the antitumor effects of omega-3 PUFAs in TNBC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“EPA and DHA also have antitumoral and anticancer properties.”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [59]
In the citing paper
“Indeed, EPA and DHA can improve drug delivery by modifying the tumor vasculature with architectural remodeling [57], and present antiangiogenic activities [58,59].”
From Microalgae n-3 PUFAs Production and Use in Food and Feed Industries (2021) · cites this paper as [59]
Citations
Cites
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Szliszka, E., Czuba, Z. P., Domino, M., Mazur, B., Zydowicz, G., & Król, W. (2009) · Molecules · doi:10.3390/molecules · Cited by 1,023
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Aung, T., Halsey, J., Kromhout, D., Gerstein, H. C., Marchioli, R., Tavazzi, L., Geleijnse, J. M., Rauch, B., Ness, A., Galan, P., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5205 · Cited by 632
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., et al. (2007) · Cancer · doi:10.1002/cncr.22836 · Cited by 602
Manson, J. E., Bassuk, S. S., Lee, I.-M., Cook, N. R., Albert, M. A., Gordon, D., Zaharris, E., MacFadyen, J. G., Danielson, E., Lin, J., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.009 · Cited by 557
Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
Bai, D., Ueno, L., & Vogt, P. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24748 · Cited by 529
Cancer as a metabolic disease: implications for novel therapeutics
Seyfried, T. N., Flores, R. E., Poff, A. M., & D'Agostino, D. P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt480 · Cited by 472
Research works printed but not linked: 3
- Aiyengar TM, 2012, J Intech, 2, 179
- Rose DP, 1990, Cancer Res, 50, 7139
- Hardman WE, 2001, Clin Cancer Res, 7, 2041
Cited by
Microalgae n-3 PUFAs Production and Use in Food and Feed Industries
Remize, M., Brunel, Y., Silva, J. L., Berthon, J.-Y., & Filaire, E. (2021) · Marine Drugs · doi:10.3390/md19020113 · Cited by 214
“Indeed, EPA and DHA can improve drug delivery by modifying the tumor vasculature with architectural remodeling [57], and present antiangiogenic activities [58,59].”
BackgroundOmega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications
Khan, I. R., Hussain, M., Jiang, B., Zheng, L., Pan, Y., Hu, J., Khan, A., Ashraf, A., & Zou, X. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101255 · Cited by 140
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Mokhtarpour, K., Razi, S., & Rezaei, N. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07387-7 · Cited by 50
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
Das, C., Bhattacharya, A., Adhikari, S., Mondal, A., Mondal, P., Adhikary, S., Roy, S., Ramos, K. S., Yadav, K. K., Tainer, J. A., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03054-9 · Cited by 45
“…the ratio of monounsaturated fatty acid (MUFA) and saturated fatty acid (SFA) and also the ratio of MUFA and polyunsaturated fatty acids (PUFA) in the plasma membrane thus increase the membrane rigidity that prevent the diffusion of chemotherapeutic drugs through the plasma membrane [165].”
BackgroundFlore, G., Deledda, A., Lombardo, M., Armani, A., & Velluzzi, F. (2023) · Antioxidants · doi:10.3390/antiox12101845 · Cited by 31
“The only supplement recommended by ESPEN for cancer cachexia is n-3 PUFAs [218], which can be of particular interest in TNBC [219].”
Background
Metadata
- Authors
- Ma, Y., Wang, J., Li, Q., & Cao, B.
- Affiliations
- Capital Medical University (CN)
- Corresponding author
- Cao, Bangwei
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2020-03-30
- Volume
- 73
- Issue
- 2
- Pages
- 196-205
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- OpenAlex
- W3013935166
- Cited by
- 27
- References
- 81
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 6 · 2023: 7 · 2022: 3 · 2021: 1
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition and Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- omega-3 polyunsaturated fatty acids, triple-negative breast cancer, docosahexaenoic acid, eicosapentaenoic acid, chemosensitization, apoptosis, PI3K/Akt signaling, dietary supplementation, anticancer activity
- MeSH terms
- Antineoplastic Agents, Humans, Fatty Acids, Omega-3, Dietary Supplements, Phosphatidylinositol 3-Kinases, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer. https://app.cochat.ai/papers/10.1080/01635581.2020.1743873
- The paper
- Ma, Y., Wang, J., Li, Q., & Cao, B. (2021). The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast Cancer. Nutrition and Cancer. https://doi.org/10.1080/01635581.2020.1743873
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.